Grab your “Pot Stock Pre-IPO” shares today! Shares could jump 270%! It’s the latest investment for the buyout boom of 2018. Just click here for details – it’s FREE.
Breweries are getting into legal weed.
The latest is Molson Coors (NYSE: TAP).
The second-largest U.S. brewery now plans to launch its own cannabis beverages in 2019.
“While we remain a beer business at our core, we are excited to create a separate new venture with a trusted partner that will be a market leader in offering Canadian consumers new experiences with quality, reliable and consistent non-alcoholic, cannabis-infused beverages,” said Molson Coors Canada President Frederic Landtmeters.
Molson Coors will partner with Hydropothecary (TSE: HEXO), a Canadian cannabis company.
This tiny “pot stock” IPO could jump 270%. It’s my #1 stock for the cannabis BUYOUT BOOM. Go here for details ASAP.
The two companies will form a new joint venture partnership. Molson Coors will retain majority control with 57.5%. The companies didn’t disclose the financial investment in the partnership.
Hydropothecary will issue Molson Coors 11.5 million warrants to purchase shares of common stock. Those warrants can be converted at a price of C$6 any time in the next three years.
If Molson Coors converts those warrants, Hydropothecary would receive $69 million in cash. Plus, Molson Coors would effectively acquire a 4.9% equity stake in the company.
This deal was a little different than the partnership between Constellation Brands (NYSE: STZ) and Canopy Growth (NYSE: CGC). With that deal, Constellation invested $191 million for a 10% equity stake in Canopy.
Shares of Hydropothecary jumped 11% on the news. Shares of Molson Coors added 6%.
The news follows similar moves into cannabis by other alcohol companies.
Heineken (OTC BB: HEINY) subsidiary Lagunitas Brewing is launching cannabis-infused sparking water in California. And the inventor of Blue Moon beer is plans to sell three marijuana drinks in Colorado this fall.
The “pot stock” buyout boom is underway. And big companies like Molson Coors are getting in on the action.
Pot Stock Briefing
Cannabis Real Estate Company Invests $13 Million in Michigan
Innovative Industrial Properties (NYSE: IIPR) is a real estate firm investing in properties for the cannabis industry. The company announced the acquisition of a 56,000-square-foot property in Michigan. The project received unanimous approval from the Michigan Medical Marijuana Licensing Board.
New $35 Million Private Equity Fund for Cannabis
Green Acre Capital is launching its second private equity fund with $35 million. Aphria (OTC BB: APHQF) was a lead investor. High-net-worth investors also contributed to the company’s second fund, focused on early-stage cannabis deals.
Tilray Cannabis Oil Phase II Clinical Trial
A new study from researchers at the Hospital for Sick Children in Toronto shows promising results for a cannabis oil from Tilray (NASDAQ: TLRY). The drug is currently in FDA Phase II trials.
One undiscovered company is quietly planning a secret IPO. Act now, and you can grab “pre-IPO” shares for less than $1. Click here for urgent details.
The overall market for cannabis stocks was largely unchanged this week.
Weekly Performance (Monday – Friday AM):
North American Index: -0.8%
Horizon Medical Marijuana ETF: -1.2%
Cannabis companies are being bought up right and left.
Last week, MedReleaf was acquired for $2.5 BILLION. And I’m expecting major news in the coming days.